If you’ve ever felt like your eyes are constantly dry, gritty, or irritated, you’re not alone. Dry eye disease is a mounting issue in today’s screen-saturated, high-speed world. For patients experiencing chronic symptoms, conventional eye drops and warm compresses may not offer long-term relief. That’s where the OptiLight Gold Standard for Dry Eye Treatment enters the picture—a state-of-the-art treatment that’s quickly becoming the standard choice for addressing dry eye, particularly in cases associated with Meibomian Gland Dysfunction (MGD).
Dry eye is when the eyes are unable to produce a sufficient quantity of tears to keep the eyes sufficiently lubricated. Excessive dry eye can lead to inflammation, discomfort, and/or blurred vision. There are two main forms of dry eye:
MGD is among the most prevalent causes of evaporative dry eye, and treating it effectively is the key to long-term relief.
Learn More: What is a Dry Eye
OptiLight is an FDA-cleared Intense Pulsed Light (IPL) treatment specifically intended to treat dry eye disease due to Meibomian Gland Dysfunction. This new treatment applies specific wavelengths of light to decrease inflammation in the eyes, clear oil-producing glands, and restore the natural harmony of your tear film.
It’s the first and sole IPL therapy cleared by the FDA for treating dry eye, establishing a new gold standard in care.
OptiLight works by delivering gentle pulses of broad-spectrum light to your skin around your eyes. The light energy will treat:
With the reduction of inflammatory factors and natural oil production restored, OptiLight restores tear film stability and comfort of the eyes. Sessions last about 10 to 15 minutes and are done in a series of four (typically every few weeks).
OptiLight is particularly effective in treating patients with moderate to severe dry eye due to MGD. You may be an ideal candidate if you:
Your eye care professional will perform a complete exam to determine whether OptiLight is appropriate for your situation.
OptiLight is not simply another treatment—it’s an all-in-one solution with long-term results. Some of its most important advantages are:
Most patients notice significant relief after only two treatments, with improvement continuing over time.
Each OptiLight treatment is quick and easy:
Some patients feel a mild snapping sensation, but overall discomfort is minimal. After treatment, you may notice slight redness, which typically fades within a few hours.
Results are variable, but most patients undergo a course of four treatments 2–4 weeks apart, followed by maintenance treatments as required.
In contrast to artificial tears or warm compresses that provide symptomatic relief, OptiLight addresses the underlying cause of dry eye—gland dysfunction and chronic inflammation. It is compatible with:
This multimodal treatment allows for more effective, sustained control of dry eye symptoms.
Yes. OptiLight has passed strict clinical trials to verify its safety and efficacy and is FDA-approved. With trained staff, side effects are minimal and normally restricted to short-term redness or warmth of the area being treated.
Dry eye disease can really get in the way of living your best life, but it doesn’t have to. With the OptiLight Gold Standard for Dry Eye Treatment, you now have access to a next-generation solution that does more than just cover up symptoms to solve the root cause.
The majority of patients receive a course of four initial treatments, with intermittent maintenance sessions thereafter.
Insurance coverage may be variable. Our staff will assist you in ascertaining whether your policy covers dry eye treatment modalities or assist in finding alternative payment arrangements.
Makeup should be avoided for 24 hours post-session to avoid increasing the risk of irritation.
Mild redness or warmth is common immediately after treatment but fades quickly. Serious side effects are rare when following the OptiLight Gold Standard for Dry Eye Treatment protocols.
Some people achieve relief by the first or second treatment, followed by ongoing improvement throughout the treatment course.
